ID   A375 NY-ESO-1 High
AC   CVCL_C3DA
DR   cancercelllines; CVCL_C3DA
DR   Sigma-Aldrich; ATG004
DR   Wikidata; Q114310505
CC   Population: Caucasian.
CC   Characteristics: Expresses CTAG1B at high level (Sigma-Aldrich=ATG004).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:2491; CTAG1B.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2491; CTAG1B.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3D8 ! A375 NY-ESO-1 Knockout
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 8
//